Bayer said it had agreed to delay a proposed settlement to deal with future claims relating to allegations that its widely used weedkiller Roundup caused cancer after a U.S. judge questioned the plan.
The German company said on Tuesday that lawyers representing those preparing a class action had withdrawn a request for court approval of the $1.25 billion scheme, part of a broader $10.9 billion agreement to settle close to 100,000 U.S. lawsuits related to Roundup.
“The withdrawal will enable the parties to more comprehensively address the questions recently raised by Federal District Court Judge Vince Chhabria of the Northern District of California who presides over the federal Roundup litigation,” Bayer said in a statement.
Last month Bayer agreed to pay as much as $10.9 billion to settle close to 100,000 U.S. lawsuits related to Roundup.
(Reporting by Keith Weir Editing by Arno Schuetze)
Was this article valuable?
Here are more articles you may enjoy.
Viewpoint: Why Florida Property Insurance Rates Might (and Might Not) Keep Falling 
PE-Backed Insurance Broker Hub International Files Confidentially for US IPO 
Viewpoint: Boom in Hyperscale Data Centers Puts Re/Insurers to the Test 
Camp Mystic Seeks Bankruptcy to Settle Texas Flood Wrongful Death Claims 
